武汉新兴精英医药有限公司

Why it is here

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — abuse of a dominant market position (竞争执法公告2017年4号武汉新兴精英医药有限公司滥用市场支配地位案), from 10 February 2017.

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Abuse of a dominant market position.

Details

Company

武汉新兴精英医药有限公司

Authority

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)

Decision

Abuse of a dominant market position

Grounds and details, as published

竞争执法公告2017年4号武汉新兴精英医药有限公司滥用市场支配地位案

From

10 February 2017

Until

—

Status

End date not published

Source

https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_d78c999de357473db4a3dcfc0e5336cc.html

Licence

Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)